Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
2.000
-0.005 (-0.25%)
At close: May 23, 2025, 4:00 PM
1.971
-0.029 (-1.43%)
After-hours: May 23, 2025, 7:10 PM EDT
Camp4 Therapeutics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Camp4 Therapeutics stock ranges from a low of $17 to a high of $23. The average analyst price target of $19.33 forecasts a 866.50% increase in the stock price over the next year.
Price Target: $19.33 (+866.50%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Camp4 Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $17 | Buy | Initiates | $17 | +750.00% | Nov 5, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $23 | Buy | Initiates | $23 | +1,050.00% | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +800.00% | Nov 5, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $8.05 → $6.9 | Strong Sell | Maintains | $8.05 → $6.9 | +245.00% | Jan 11, 2024 |
Financial Forecast
Revenue This Year
884.85K
from 652.00K
Increased by 35.71%
Revenue Next Year
102.00K
from 884.85K
Decreased by -88.47%
EPS This Year
-3.00
from -11.04
EPS Next Year
-2.70
from -3.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.7M | 420,000 | n/a |
| Avg | 884,850 | 102,000 | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 314.0% | -52.5% | - |
| Avg | 35.7% | -88.5% | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.80 | -2.08 | -2.68 |
| Avg | -3.00 | -2.70 | -2.86 |
| Low | -3.23 | -3.15 | -2.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.